Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Ind-Swift Laboratories share price/ Ind-Swift Laboratories Profit Loss Annual
Ind-Swift Laboratories Profit & Loss Annual
Trade99.85 -2.00 (-1.96%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 1,280.90 | 1,207.31 | 1,038.73 | 891.34 |
| Total Revenue | 1,280.90 | 1,207.31 | 1,038.73 | 891.34 |
| Costof Revenue Total | 661.46 | 750.08 | 614.28 | 503.18 |
| Gross Profit | 619.44 | 457.23 | 424.45 | 388.16 |
| Selling/ General/ Admin Expenses Total | 152.81 | 228.03 | 228.83 | 172.33 |
| Depreciation/ Amortization | 53.30 | 57.08 | 131.04 | 87.01 |
| Unusual Expense( Income) | -386.59 | 26.65 | - | - |
| Other Operating Expenses Total | 212.42 | -8.62 | -14.17 | -15.43 |
| Total Operating Expense | 693.41 | 1,053.50 | 959.98 | 780.38 |
| Operating Income | 587.49 | 153.81 | 78.76 | 110.96 |
| Interest Inc( Exp) Net- Non- Op Total | -511.04 | -624.34 | -761.28 | -895.68 |
| Other Net | 45.37 | -4.86 | 9.90 | -3.38 |
| Net Income Before Taxes | 581.76 | 86.52 | 12.53 | 18.01 |
| Provisionfor Income Taxes | 160.31 | 38.69 | 14.68 | 21.16 |
| Net Income After Taxes | 421.45 | 47.83 | -2.15 | -3.15 |
| Equity In Affiliates | -4.90 | -2.34 | 0.00 | - |
| Net Income Before Extra Items | 420.96 | 47.60 | -2.15 | -3.15 |
| Net Income | 420.96 | 47.60 | -2.15 | -3.15 |
| Income Availableto Com Excl Extra Ord | 420.96 | 47.60 | -2.15 | -3.15 |
| Income Availableto Com Incl Extra Ord | 420.96 | 47.60 | -2.15 | -3.15 |
| Diluted Net Income | 420.96 | 47.60 | -2.15 | -3.15 |
| Diluted Weighted Average Shares | 5.91 | 5.91 | 5.91 | 5.91 |
| Diluted EPS Excluding Extra Ord Items | 71.24 | 8.06 | -0.36 | -0.53 |
| Diluted Normalized EPS | 23.84 | 10.55 | -0.36 | -0.53 |
| Interest Exp( Inc) Net- Operating Total | - | 2.82 | - | 2.82 |
| Total Adjustmentsto Net Income | - | 0.00 | - | - |
| Research Development | - | - | - | 330.13 |
| Gain( Loss)on Saleof Assets | - | - | - | 0.00 |
*All figures in crores except per share values
Ind-Swift Laboratories Quick Links
Ind-Swift Laboratories Dividend Ind-Swift Laboratories Bonus Ind-Swift Laboratories News Ind-Swift Laboratories AGM Ind-Swift Laboratories Rights Ind-Swift Laboratories Splits Ind-Swift Laboratories Board Meetings Ind-Swift Laboratories Key Metrics Ind-Swift Laboratories Shareholdings Ind-Swift Laboratories Balance Sheet Ind-Swift Laboratories Cashflow Ind-Swift Laboratories Q1 Results Ind-Swift Laboratories Q2 Results Ind-Swift Laboratories Q3 Results Ind-Swift Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)